Abstract
B ecause of the hepatotrophic properties of portal flow,' preoperative selective portal vein embolization (PSPVE) may be a safe method to induce atrophy of the embolized portion of liver before resection and a compensatory hypertrophy in the future remnant liver. This technique recently has become important in the preoperative management of patients who must undergo extensive liver resection,2-4 improving operability and avoiding life-threatening postoperative liver failure5~~ when there is a risk for insufficient remaining liver parenchyma after surgery. In clinical practice, this can occur in cases of: (I) a small left lobe and the need for extended or normal right hepatectomy; (2) major liver surgery in patients with liver function impaired by cirrhosis, severe cholestasis, or primary or postchemotherapeutic secondary fibrosis; and (3) severe fatty steatosis. The fact that PSPVE is well tolerated might expand its indications in the future to increase the safety
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.